2008 Portfolio News
News from the portfolios of HBM BioVentures and HBM BioCapital
Basilea's Ceftobiprole, a new anti-MRSA broad-spectrum antibiotic, receives its first marketing authorization by Health Canada (35 KB)30.06.2008
- Ipsen to acquire Tercica (18 KB)
04.06.2008
- PharmaSwiss raises EUR 35 million from private equity fund (41 KB)
20.05.2008
- Onyx' Nexavar significantly improves overall survival by 47% in Asia-Pacific liver cancer study (89 KB)
16.05.2008
- Pelikan Technologies and Lilly form alliance to promote diabetes education (26 KB)
16.04.2008
- Paratek Pharmaceuticals completes $40 Million private placement to finance clinical programs including oral anti-MRSA antibiotics (31 KB)
16.04.2008
- Newron reports positive Phase II results for ralfinamide in peripheral neuropathic pain patients (82 KB)
16.04.2008
- BRAHMS AG: receives FDA clearance to market automated procalcitonin (PCT) test (25 KB)
07.04.2008
- ESBATech's antibody fragments demonstrate penetration into the eye with topical delivery via eye drops (220 KB)
25.02.2008
- Surface Logix reports phase 2A on SLX-4090 (23 KB)
29.01.2008
News
M&A Report
Links
Subscribe To Our Newsletter
Search
© HBM Partners AG 18.05.2012